Retatrutide Side Effects by Dose: 4mg vs 8mg vs 12mg
Retatrutide's Phase 2 trial tested multiple dose levels, providing detailed side effect data across the dose range. Understanding how side effects scale with dose helps patients and providers make informed decisions about the optimal balance between efficacy and tolerability (Jastreboff et al., NEJM 2023). The 4mg dose produces 17.5% weight loss with lower side effects, while 12mg produces 24.2% with moderately higher rates of certain effects.
Medical Disclaimer: This article is for informational purposes only. Retatrutide is an investigational drug not yet approved by the FDA. Dose selection should be made by your healthcare provider based on individual response and tolerability. Never adjust doses without medical guidance.
Complete Side Effect Breakdown by Dose
| Side Effect | Placebo | 4mg | 8mg | 12mg |
|---|---|---|---|---|
| Nausea | 6% | 16% | 22% | 26% |
| Diarrhea | 8% | 18% | 25% | 22% |
| Vomiting | 2% | 8% | 10% | 13% |
| Constipation | 4% | 10% | 12% | 14% |
| Dysesthesia | 2% | 6% | 13% | 20.9% |
| Heart rate increase | 0-1 bpm | 1-2 bpm | 2-3 bpm | 2-4 bpm |
| Weight loss | 2.1% | 17.5% | 22.8% | 24.2% |
Approximate rates from Jastreboff et al., NEJM 2023.
Key Observations
Most GI effects plateau between 8mg and 12mg. The jump from 4mg to 8mg produces more additional GI side effects than the jump from 8mg to 12mg. Meanwhile, weight loss continues to increase from 8mg to 12mg. This suggests the 8mg-to-12mg escalation provides meaningful additional weight loss with relatively modest additional side effects.
Dysesthesia is strongly dose-dependent. This glucagon-specific effect shows the clearest dose-response relationship, jumping from 6% at 4mg to 20.9% at 12mg. Patients who find this intolerable at 12mg can often manage well at 8mg.
4mg is highly effective. The 4mg dose produces 17.5% weight loss — more than semaglutide — with substantially lower side effect rates. For patients prioritizing tolerability, 4mg may be the optimal maintenance dose.
Choosing the Right Dose
- 4mg: Best for patients who prioritize tolerability, who achieve sufficient weight loss at this level, or who have significant side effect sensitivity
- 8mg: The sweet spot for many patients — significantly more weight loss than 4mg with moderate side effect increase
- 12mg: Maximum efficacy for patients who tolerate lower doses well and need maximum weight loss
Start GLP-1 Treatment Today
Trimi offers compounded semaglutide ($99/month) and compounded tirzepatide ($125/month) with dose titration guided by your response and tolerability. Get started with Trimi.
Frequently Asked Questions
What is the best dose of retatrutide?
It depends on individual goals and tolerability. The 12mg dose provides maximum weight loss but with higher side effect rates. The 4mg dose provides excellent weight loss with fewer side effects. Most patients may find 8mg offers the best balance.
Can I stay on a lower dose if I'm losing enough weight?
Yes. Dose selection should be based on clinical response and tolerability, not a one-size-fits-all target. If 4mg or 8mg achieves your goals, escalating to 12mg is not necessary.
Do side effects get worse with each dose increase?
Side effects typically recur temporarily with each dose increase but are most pronounced during the first dose increase. The GI tract partially adapts, so subsequent increases may be better tolerated.
Can I reduce my dose if side effects are too much?
Yes. Dose reduction is a standard strategy for managing intolerable side effects. Discuss with your healthcare provider.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).